These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Pre-operative Diagnosis of Silent Coronary Ischaemia May Reduce Post-operative Death and Myocardial Infarction and Improve Survival of Patients Undergoing Lower Extremity Surgical Revascularisation. Krievins D; Zellans E; Latkovskis G; Erglis A; Zvaigzne L; Kumsars I; Rumba R; Stradins P; Jegere S; Zarins CK Eur J Vasc Endovasc Surg; 2020 Sep; 60(3):411-420. PubMed ID: 32709470 [TBL] [Abstract][Full Text] [Related]
31. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease. Bravo CA; Hirji SA; Bhatt DL; Kataria R; Faxon DP; Ohman EM; Anderson KL; Sidi AI; Sketch MH; Zarich SW; Osho AA; Gluud C; Kelbæk H; Engstrøm T; Høfsten DE; Brennan JM Cochrane Database Syst Rev; 2017 May; 5(5):CD011986. PubMed ID: 28470696 [TBL] [Abstract][Full Text] [Related]
32. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity. Reynolds HR; Shaw LJ; Min JK; Page CB; Berman DS; Chaitman BR; Picard MH; Kwong RY; O'Brien SM; Huang Z; Mark DB; Nath RK; Dwivedi SK; Smanio PEP; Stone PH; Held C; Keltai M; Bangalore S; Newman JD; Spertus JA; Stone GW; Maron DJ; Hochman JS Circulation; 2021 Sep; 144(13):1024-1038. PubMed ID: 34496632 [TBL] [Abstract][Full Text] [Related]
33. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis. Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745 [TBL] [Abstract][Full Text] [Related]
34. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS; Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098 [TBL] [Abstract][Full Text] [Related]
35. ISCHEMIA Trial and the Significance of MI. Arias EA; Damas-de Los Santos F; Ontiveros-Mercado H Interv Cardiol; 2020 Apr; 15():e14. PubMed ID: 33163087 [TBL] [Abstract][Full Text] [Related]
36. Techniques and approaches for revascularisation of left heart coronary diseases. Maskell P; Oo S; Muir AD; Fan KS; Harky A Br J Hosp Med (Lond); 2020 Aug; 81(8):1-11. PubMed ID: 32845756 [TBL] [Abstract][Full Text] [Related]
37. Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial. Heutinck JM; De Koning IA; Vromen T; Van Geuns RM; Thijssen DHJ; Kemps HMC; BMC Cardiovasc Disord; 2023 May; 23(1):238. PubMed ID: 37147562 [TBL] [Abstract][Full Text] [Related]